8EYB image
Entry Detail
PDB ID:
8EYB
Title:
Crystal structure of PTP1B D181A/Q262A/C215A phosphatase domain with JAK2 activation loop phosphopeptide
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2022-10-26
Release Date:
2023-07-05
Method Details:
Experimental Method:
Resolution:
2.35 Å
R-Value Free:
0.24
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Tyrosine-protein phosphatase non-receptor type 1
Mutations:D181A/Q262A/C215A
Chain IDs:A, B
Chain Length:296
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Tyrosine-protein kinase JAK2 activation loop phosphopeptide
Chain IDs:C (auth: D), D (auth: E)
Chain Length:16
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
PTR C TYR modified residue
Ligand Molecules
Primary Citation
Structure guided studies of the interaction between PTP1B and JAK.
Commun Biol 6 641 641 (2023)
PMID: 37316570 DOI: 10.1038/s42003-023-05020-9

Abstact

Protein Tyrosine Phosphatase 1B (PTP1B) is the prototypical protein tyrosine phosphatase and plays an essential role in the regulation of several kinase-driven signalling pathways. PTP1B displays a preference for bisphosphorylated substrates. Here we identify PTP1B as an inhibitor of IL-6 and show that, in vitro, it can dephosphorylate all four members of the JAK family. In order to gain a detailed understanding of the molecular mechanism of JAK dephosphorylation, we undertook a structural and biochemical analysis of the dephosphorylation reaction. We identified a product-trapping PTP1B mutant that allowed visualisation of the tyrosine and phosphate products of the reaction and a substrate-trapping mutant with a vastly decreased off-rate compared to those previously described. The latter mutant was used to determine the structure of bisphosphorylated JAK peptides bound to the enzyme active site. These structures revealed that the downstream phosphotyrosine preferentially engaged the active site, in contrast to the analogous region of IRK. Biochemical analysis confirmed this preference. In this binding mode, the previously identified second aryl binding site remains unoccupied and the non-substrate phosphotyrosine engages Arg47. Mutation of this arginine disrupts the preference for the downstream phosphotyrosine. This study reveals a previously unappreciated plasticity in how PTP1B interacts with different substrates.

Legend

Protein

Chemical

Disease

Primary Citation of related structures